The Chronic Migraine Treatment Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Chronic migraine is a debilitating neurological disorder that affects millions of people worldwide. The global Chronic Migraine Treatment Market is growing hugely on account of rising prevalence of migraines and increasing awareness among people, coupled with advancements in therapeutic options. This detailed market research report provides an in-depth study of the intricate dynamics of the Chronic Migraine Treatment Market to understand the current landscape and growth trajectories in detail. It also guides readers to identify the main players and emerging trends.
Purpose of the ReportThe report Chronic Migraine Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Chronic Migraine Treatment Market Segmentation
Treatment- Abortive Treatment
- Prophylactic Treatment
- Oral
- Injectable
- Hospitals Pharmacies
- Retail Pharmacies
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Chronic Migraine Treatment Market Growth Drivers- Rise in Migrein in youth: The primary growth driver for the global chronic migraine treatment market has been the incidence of migraines among the younger population. The growing awareness regarding the severity of migraine and the need for proper treatments have also created momentum in the market. Alongside, An increased population of patients in the geriatric segment makes them more liable to be attacked.
- Growing Medical Research and New Therapies: The medical research world is changing at a particularly rapid speed and with the advent of new therapies, including CGRP inhibitors and monoclonal antibodies, entering the market at an accelerated rate, thereby increasing treatment options and outcomes for patients.
- Greater health care expenditure: Rising healthcare expenditure and disposable incomes have been highly supportive for improving easier access towards the upper end of treatments. Besides this, research being undertaken by the governments to alerting people towards superior health care infrastructure shall increase market further.
- Technological Advancements: Neuroscience advancement and biotechnology shall lead to finding novel therapies that particularly target migraine mechanisms. Under personalized medicine, approaches shall be tailored to treatment strategies accounting for individual genetic and physiologic factors. In terms of device technologies, such as wearables and mobile apps, under devices technologies, digital health technologies shall empower the patient to track and manage their migraines much better.
- Preventive Strategies: There shall be increased attention toward preventive strategies, including lifestyle changes, and stress management procedures accompaniment of the pharmacological-based treatments.
- Emergence of Combination Therapies: The emerging pathophysiology of migraine will pave the way for combination therapies and targeted drug delivery systems that are going to improve in the market. The growing incidence of migraine in the emerging markets is emerging as a growth opportunity. On the whole, the Chronic Migraine Treatment Market is full of promise and promises patient outcomes and quality of life.
- Growth in Non-Pharmacological Therapies: Nondrug therapies such as neuromodulation, biofeedback, and cognitive-behavioral therapy are becoming popular for the management of chronic migraines in a holistic way. These provide an alternative or an adjunctive treatment for patients who prefer to shift from traditional pharmacological treatment options, thus increasing the demand for noninvasive therapies.
- Innovations in CGRP Inhibitors: CGRP inhibitors (Calcitonin Gene-Related Peptide) represent a novel class of drugs in the treatment of migraine. This new class of drugs, which includes erenumab and fremanezumab, has shown high efficacy in reducing the frequency and severity of migraine attacks and, therefore, represents a new therapeutic landscape.
- Preventive Migraine Treatments: Preventive rather than acute treatment therapies are gaining popularity in treating chronic migraines less frequently and severely, with such options as monoclonal antibodies, botulinum toxin injections, and anti-seizure medications. Such treatments offer a long-term solution for chronic migraine patients.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Chronic Migraine Treatment Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Chronic Migraine Treatment Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The leading players of the market are: Alder BioPharmaceutical, Inc., Allergan plc., AstraZeneca plc., Eisai Co., Ltd., Eli Lilly & Company, Endo Pharmaceutical Inc.,, GlaxoSmithKline plc., Janssen Pharmaceutical Company (Johnson & Johnson), Merck & Co., Inc., Zosano Pharma Corporation
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The chronic migraine treatment market is set for a bright future. It is expected to grow further and expand with new inventions in neuroscience and biotechnology, which will introduce novel therapies attacking specific mechanisms involved in migraine pathology. Such specific personalized medicine approaches, guided by a person's unique genomic makeup and physiological differences, will allow for tailored treatment strategies. The new generation of digital health technologies-the wearable devices and mobile apps-will enable patients to diagnose and manage their attacks effectively. Greater emphasis on preventive measures, such as lifestyle adjustments and stress management techniques, also will be part of the toolkit. Combination therapies and targeted drug delivery systems are expected to emerge in the market as understanding of the pathophysiology of migraines increases. With increasing prevalence of migraine in emerging markets, further growth is expected to come from there. In general, the outlook for the Chronic Migraine Treatment Market seems optimistic, focusing on quality of life and patient outcome.
Chronic Migraine Treatment Market is expected to grow at a CAGR of 6.8% between 2023-2031
It is driven by various drivers, such as the increasing prevalence of migraines in general, but significantly, in younger populations worldwide. Greater awareness regarding migraine as a serious medical condition and the requirement for effective treatments is increasing market demand. The factor of advancing research in medical science and innovative therapies in the form of CGRP inhibitors and monoclonal antibodies is expanding and improving treatments and patient outcomes. Increasing geriatric population, who are more vulnerable to migraine attacks, is adding on to the growth of the market. Rising healthcare expenditure and growing disposable incomes are also helping improve access to sophisticated treatments.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chronic Migraine Treatment Market - By Treatment
1.3.2 Chronic Migraine Treatment Market - By Route of Administration
1.3.3 Chronic Migraine Treatment Market - By Distribution Channel
1.3.4 Chronic Migraine Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHRONIC MIGRAINE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHRONIC MIGRAINE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CHRONIC MIGRAINE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. CHRONIC MIGRAINE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. CHRONIC MIGRAINE TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CHRONIC MIGRAINE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. ABORTIVE TREATMENT
7.3.1. Overview
7.3.2. Abortive Treatment Market Forecast and Analysis
7.3.3. Triptans Market
7.3.3.1. Overview
7.3.3.2. Triptans Market Forecast and Analysis
7.3.4. Ergot Alkaloids Market
7.3.4.1. Overview
7.3.4.2. Ergot Alkaloids Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. PROPHYLACTIC TREATMENT
7.4.1. Overview
7.4.2. Prophylactic Treatment Market Forecast and Analysis
7.4.3. Botulinum Toxin Market
7.4.3.1. Overview
7.4.3.2. Botulinum Toxin Market Forecast and Analysis
7.4.4. Topiramate Market
7.4.4.1. Overview
7.4.4.2. Topiramate Market Forecast and Analysis
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis
8. CHRONIC MIGRAINE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
8.5. OTHERS (NASAL SPRAY, TRANSDERMAL PATCH, SUPPOSITORIES)
8.5.1. Overview
8.5.2. Others (Nasal Spray, Transdermal Patch, suppositories) Market Forecast and Analysis
9. CHRONIC MIGRAINE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS PHARMACIES
9.3.1. Overview
9.3.2. Hospitals Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. OTHERS (ONLINE PHARMACIES, DRUG STORES)
9.5.1. Overview
9.5.2. Others (Online Pharmacies, Drug Stores) Market Forecast and Analysis
10. CHRONIC MIGRAINE TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Chronic Migraine Treatment Market Overview
10.1.2 North America Chronic Migraine Treatment Market Forecasts and Analysis
10.1.3 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.1.4 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Chronic Migraine Treatment Market
10.1.6.1.1 United States Chronic Migraine Treatment Market by Treatment
10.1.6.1.2 United States Chronic Migraine Treatment Market by Route of Administration
10.1.6.1.3 United States Chronic Migraine Treatment Market by Distribution Channel
10.1.6.2 Canada Chronic Migraine Treatment Market
10.1.6.2.1 Canada Chronic Migraine Treatment Market by Treatment
10.1.6.2.2 Canada Chronic Migraine Treatment Market by Route of Administration
10.1.6.2.3 Canada Chronic Migraine Treatment Market by Distribution Channel
10.1.6.3 Mexico Chronic Migraine Treatment Market
10.1.6.3.1 Mexico Chronic Migraine Treatment Market by Treatment
10.1.6.3.2 Mexico Chronic Migraine Treatment Market by Route of Administration
10.1.6.3.3 Mexico Chronic Migraine Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Chronic Migraine Treatment Market Overview
10.2.2 Europe Chronic Migraine Treatment Market Forecasts and Analysis
10.2.3 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.2.4 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Chronic Migraine Treatment Market
10.2.6.1.1 Germany Chronic Migraine Treatment Market by Treatment
10.2.6.1.2 Germany Chronic Migraine Treatment Market by Route of Administration
10.2.6.1.3 Germany Chronic Migraine Treatment Market by Distribution Channel
10.2.6.2 France Chronic Migraine Treatment Market
10.2.6.2.1 France Chronic Migraine Treatment Market by Treatment
10.2.6.2.2 France Chronic Migraine Treatment Market by Route of Administration
10.2.6.2.3 France Chronic Migraine Treatment Market by Distribution Channel
10.2.6.3 Italy Chronic Migraine Treatment Market
10.2.6.3.1 Italy Chronic Migraine Treatment Market by Treatment
10.2.6.3.2 Italy Chronic Migraine Treatment Market by Route of Administration
10.2.6.3.3 Italy Chronic Migraine Treatment Market by Distribution Channel
10.2.6.4 Spain Chronic Migraine Treatment Market
10.2.6.4.1 Spain Chronic Migraine Treatment Market by Treatment
10.2.6.4.2 Spain Chronic Migraine Treatment Market by Route of Administration
10.2.6.4.3 Spain Chronic Migraine Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Chronic Migraine Treatment Market
10.2.6.5.1 United Kingdom Chronic Migraine Treatment Market by Treatment
10.2.6.5.2 United Kingdom Chronic Migraine Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Chronic Migraine Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Chronic Migraine Treatment Market Overview
10.3.2 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.3.4 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Chronic Migraine Treatment Market
10.3.6.1.1 Australia Chronic Migraine Treatment Market by Treatment
10.3.6.1.2 Australia Chronic Migraine Treatment Market by Route of Administration
10.3.6.1.3 Australia Chronic Migraine Treatment Market by Distribution Channel
10.3.6.2 China Chronic Migraine Treatment Market
10.3.6.2.1 China Chronic Migraine Treatment Market by Treatment
10.3.6.2.2 China Chronic Migraine Treatment Market by Route of Administration
10.3.6.2.3 China Chronic Migraine Treatment Market by Distribution Channel
10.3.6.3 India Chronic Migraine Treatment Market
10.3.6.3.1 India Chronic Migraine Treatment Market by Treatment
10.3.6.3.2 India Chronic Migraine Treatment Market by Route of Administration
10.3.6.3.3 India Chronic Migraine Treatment Market by Distribution Channel
10.3.6.4 Japan Chronic Migraine Treatment Market
10.3.6.4.1 Japan Chronic Migraine Treatment Market by Treatment
10.3.6.4.2 Japan Chronic Migraine Treatment Market by Route of Administration
10.3.6.4.3 Japan Chronic Migraine Treatment Market by Distribution Channel
10.3.6.5 South Korea Chronic Migraine Treatment Market
10.3.6.5.1 South Korea Chronic Migraine Treatment Market by Treatment
10.3.6.5.2 South Korea Chronic Migraine Treatment Market by Route of Administration
10.3.6.5.3 South Korea Chronic Migraine Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Chronic Migraine Treatment Market Overview
10.4.2 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.4.4 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Chronic Migraine Treatment Market
10.4.6.1.1 South Africa Chronic Migraine Treatment Market by Treatment
10.4.6.1.2 South Africa Chronic Migraine Treatment Market by Route of Administration
10.4.6.1.3 South Africa Chronic Migraine Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Chronic Migraine Treatment Market
10.4.6.2.1 Saudi Arabia Chronic Migraine Treatment Market by Treatment
10.4.6.2.2 Saudi Arabia Chronic Migraine Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Chronic Migraine Treatment Market by Distribution Channel
10.4.6.3 U.A.E Chronic Migraine Treatment Market
10.4.6.3.1 U.A.E Chronic Migraine Treatment Market by Treatment
10.4.6.3.2 U.A.E Chronic Migraine Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Chronic Migraine Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Chronic Migraine Treatment Market Overview
10.5.2 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis
10.5.3 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.5.4 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Chronic Migraine Treatment Market
10.5.6.1.1 Brazil Chronic Migraine Treatment Market by Treatment
10.5.6.1.2 Brazil Chronic Migraine Treatment Market by Route of Administration
10.5.6.1.3 Brazil Chronic Migraine Treatment Market by Distribution Channel
10.5.6.2 Argentina Chronic Migraine Treatment Market
10.5.6.2.1 Argentina Chronic Migraine Treatment Market by Treatment
10.5.6.2.2 Argentina Chronic Migraine Treatment Market by Route of Administration
10.5.6.2.3 Argentina Chronic Migraine Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHRONIC MIGRAINE TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ALDER BIOPHARMACEUTICAL, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EISAI CO., LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ENDO PHARMACEUTICAL INC.,
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JANSSEN PHARMACEUTICAL COMPANY (JOHNSON AND JOHNSON)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZOSANO PHARMA CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Alder BioPharmaceutical, Inc.
2. Allergan plc.
3. AstraZeneca plc.
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. Endo Pharmaceutical Inc.,
7. GlaxoSmithKline plc.
8. Janssen Pharmaceutical Company (Johnson and Johnson)
9. Merck and Co., Inc.
10. Zosano Pharma Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For